UniProt ID | ZBT17_HUMAN | |
---|---|---|
UniProt AC | Q13105 | |
Protein Name | Zinc finger and BTB domain-containing protein 17 | |
Gene Name | ZBTB17 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 803 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor that can function as an activator or repressor depending on its binding partners, and by targeting negative regulators of cell cycle progression. Plays a critical role in early lymphocyte development, where it is essential to prevent apoptosis in lymphoid precursors, allowing them to survive in response to IL7 and undergo proper lineage commitment. Has been shown to bind to the promoters of adenovirus major late protein and cyclin D1 and activate transcription. Required for early embryonic development during gastrulation. Represses RB1 transcription; this repression can be blocked by interaction with ZBTB49 isoform 3/ZNF509S1. [PubMed: 25245946] | |
Protein Sequence | MDFPQHSQHVLEQLNQQRQLGLLCDCTFVVDGVHFKAHKAVLAACSEYFKMLFVDQKDVVHLDISNAAGLGQVLEFMYTAKLSLSPENVDDVLAVATFLQMQDIITACHALKSLAEPATSPGGNAEALATEGGDKRAKEEKVATSTLSRLEQAGRSTPIGPSRDLKEERGGQAQSAASGAEQTEKADAPREPPPVELKPDPTSGMAAAEAEAALSESSEQEMEVEPARKGEEEQKEQEEQEEEGAGPAEVKEEGSQLENGEAPEENENEESAGTDSGQELGSEARGLRSGTYGDRTESKAYGSVIHKCEDCGKEFTHTGNFKRHIRIHTGEKPFSCRECSKAFSDPAACKAHEKTHSPLKPYGCEECGKSYRLISLLNLHKKRHSGEARYRCEDCGKLFTTSGNLKRHQLVHSGEKPYQCDYCGRSFSDPTSKMRHLETHDTDKEHKCPHCDKKFNQVGNLKAHLKIHIADGPLKCRECGKQFTTSGNLKRHLRIHSGEKPYVCIHCQRQFADPGALQRHVRIHTGEKPCQCVMCGKAFTQASSLIAHVRQHTGEKPYVCERCGKRFVQSSQLANHIRHHDNIRPHKCSVCSKAFVNVGDLSKHIIIHTGEKPYLCDKCGRGFNRVDNLRSHVKTVHQGKAGIKILEPEEGSEVSVVTVDDMVTLATEALAATAVTQLTVVPVGAAVTADETEVLKAEISKAVKQVQEEDPNTHILYACDSCGDKFLDANSLAQHVRIHTAQALVMFQTDADFYQQYGPGGTWPAGQVLQAGELVFRPRDGAEGQPALAETSPTAPECPPPAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
113 | Phosphorylation | TACHALKSLAEPATS HHHHHHHHHCCCCCC | 33.39 | 29255136 | |
119 | Phosphorylation | KSLAEPATSPGGNAE HHHCCCCCCCCCCHH | 46.28 | 23401153 | |
120 | Phosphorylation | SLAEPATSPGGNAEA HHCCCCCCCCCCHHH | 24.53 | 29255136 | |
130 | Phosphorylation | GNAEALATEGGDKRA CCHHHHHCCCCCHHH | 35.69 | 30278072 | |
135 (in isoform 2) | Ubiquitination | - | 58.49 | 21906983 | |
135 (in isoform 1) | Ubiquitination | - | 58.49 | 21906983 | |
135 | Ubiquitination | LATEGGDKRAKEEKV HHCCCCCHHHHHHHH | 58.49 | 21906983 | |
156 | Phosphorylation | RLEQAGRSTPIGPSR HHHHCCCCCCCCCCC | 37.30 | 30624053 | |
157 | Phosphorylation | LEQAGRSTPIGPSRD HHHCCCCCCCCCCCC | 19.98 | 25849741 | |
162 | Phosphorylation | RSTPIGPSRDLKEER CCCCCCCCCCCCHHH | 32.96 | - | |
169 | Methylation | SRDLKEERGGQAQSA CCCCCHHHCCCHHHH | 56.48 | 115920305 | |
175 | Phosphorylation | ERGGQAQSAASGAEQ HHCCCHHHHHCCHHH | 28.90 | - | |
178 | Phosphorylation | GQAQSAASGAEQTEK CCHHHHHCCHHHHHC | 37.95 | - | |
202 | Phosphorylation | VELKPDPTSGMAAAE CCCCCCCCCHHHHHH | 45.34 | 29449344 | |
203 | Phosphorylation | ELKPDPTSGMAAAEA CCCCCCCCHHHHHHH | 31.77 | 22210691 | |
215 | Phosphorylation | AEAEAALSESSEQEM HHHHHHHCCCCHHHH | 30.61 | 29449344 | |
217 | Phosphorylation | AEAALSESSEQEMEV HHHHHCCCCHHHHCC | 35.48 | 22210691 | |
218 | Phosphorylation | EAALSESSEQEMEVE HHHHCCCCHHHHCCC | 38.97 | 22210691 | |
255 | Phosphorylation | AEVKEEGSQLENGEA HHHHHHCCCCCCCCC | 34.57 | 21406692 | |
271 (in isoform 2) | Phosphorylation | - | 26.31 | 21406692 | |
271 | Phosphorylation | EENENEESAGTDSGQ CCCCCCCCCCCCCHH | 26.31 | 30576142 | |
274 | Phosphorylation | ENEESAGTDSGQELG CCCCCCCCCCHHHHH | 27.06 | 30576142 | |
274 (in isoform 2) | Phosphorylation | - | 27.06 | 21406692 | |
276 | Phosphorylation | EESAGTDSGQELGSE CCCCCCCCHHHHHHH | 42.06 | 21406692 | |
276 (in isoform 2) | Phosphorylation | - | 42.06 | 21406692 | |
282 | Phosphorylation | DSGQELGSEARGLRS CCHHHHHHHHHCCCC | 40.48 | 21406692 | |
291 | Phosphorylation | ARGLRSGTYGDRTES HHCCCCCCCCCCCCC | 26.10 | - | |
292 | Phosphorylation | RGLRSGTYGDRTESK HCCCCCCCCCCCCCC | 22.13 | - | |
301 (in isoform 2) | Phosphorylation | - | 17.42 | 27642862 | |
329 | Phosphorylation | KRHIRIHTGEKPFSC EEEEEEECCCCCCCH | 44.67 | - | |
332 | Ubiquitination | IRIHTGEKPFSCREC EEEECCCCCCCHHHH | 53.35 | 21906983 | |
332 (in isoform 2) | Ubiquitination | - | 53.35 | 21906983 | |
332 (in isoform 1) | Ubiquitination | - | 53.35 | 21906983 | |
341 | Ubiquitination | FSCRECSKAFSDPAA CCHHHHHHHHCCHHH | 66.17 | 21906983 | |
341 (in isoform 1) | Ubiquitination | - | 66.17 | 21906983 | |
341 (in isoform 2) | Ubiquitination | - | 66.17 | 21906983 | |
350 (in isoform 1) | Ubiquitination | - | 48.31 | 21906983 | |
350 (in isoform 2) | Ubiquitination | - | 48.31 | 21906983 | |
350 | Ubiquitination | FSDPAACKAHEKTHS HCCHHHHHHCCCCCC | 48.31 | 2190698 | |
355 | Phosphorylation | ACKAHEKTHSPLKPY HHHHCCCCCCCCCCC | 25.30 | 28387310 | |
357 | Phosphorylation | KAHEKTHSPLKPYGC HHCCCCCCCCCCCCC | 36.84 | 23401153 | |
360 | Ubiquitination | EKTHSPLKPYGCEEC CCCCCCCCCCCCCCC | 39.31 | - | |
362 | Phosphorylation | THSPLKPYGCEECGK CCCCCCCCCCCCCCC | 32.59 | 18083107 | |
371 | Phosphorylation | CEECGKSYRLISLLN CCCCCCHHHHHHHHC | 16.96 | 18083107 | |
406 | Ubiquitination | FTTSGNLKRHQLVHS EECCCCCCEEEEECC | 52.41 | - | |
413 | Phosphorylation | KRHQLVHSGEKPYQC CEEEEECCCCCCEEC | 40.96 | - | |
426 | Phosphorylation | QCDYCGRSFSDPTSK ECCCCCCCCCCCCHH | 17.87 | 29052541 | |
428 | Phosphorylation | DYCGRSFSDPTSKMR CCCCCCCCCCCHHCC | 43.88 | 29052541 | |
431 | Phosphorylation | GRSFSDPTSKMRHLE CCCCCCCCHHCCCCC | 46.07 | 29052541 | |
432 | Phosphorylation | RSFSDPTSKMRHLET CCCCCCCHHCCCCCC | 29.82 | 29052541 | |
433 | Acetylation | SFSDPTSKMRHLETH CCCCCCHHCCCCCCC | 42.29 | 20167786 | |
462 | Ubiquitination | FNQVGNLKAHLKIHI CCCCCCHHHEEEEEE | 37.45 | - | |
497 | Phosphorylation | KRHLRIHSGEKPYVC HHEEEEECCCCCEEE | 46.40 | 29214152 | |
525 | Phosphorylation | QRHVRIHTGEKPCQC HHCEEEECCCCCEEE | 44.67 | - | |
570 | Phosphorylation | CGKRFVQSSQLANHI CCCCHHHHHHHHHHH | 18.10 | - | |
609 | Phosphorylation | SKHIIIHTGEKPYLC HCEEEEECCCCCCCC | 36.31 | 29214152 | |
791 | Phosphorylation | GQPALAETSPTAPEC CCCCCCCCCCCCCCC | 34.11 | 26074081 | |
792 | Phosphorylation | QPALAETSPTAPECP CCCCCCCCCCCCCCC | 16.26 | 30576142 | |
794 | Phosphorylation | ALAETSPTAPECPPP CCCCCCCCCCCCCCC | 55.39 | 30576142 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
397 | K | ubiquitylation |
| - |
481 | K | ubiquitylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZBT17_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...